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Abstract 27 
Effective wastewater management is crucial to ensure the safety of water reuse projects and 28 
effluent discharge into surface waters. Multiple studies have demonstrated that municipal 29 
wastewater treatment with conventional activated sludge processes is inefficient for the removal 30 
of the wide spectrum of viruses in sewage. In this study, a well-accepted statistical approach was 31 
used to investigate the relationship between viral indicators and human enteric viruses during 32 
wastewater treatment in a resource-limited region. Influent and effluent samples from five urban 33 
wastewater treatment plants (WWTP) in Costa Rica were analyzed for somatic coliphage and 34 
human enterovirus, hepatitis A virus, norovirus genotype I and II, and rotavirus. All WWTP 35 
provide primary treatment followed by conventional activated sludge treatment prior to 36 
discharge into surface waters that are indirectly used for agricultural irrigation. The results 37 
revealed a statistically significant relationship between the detection of at least one of the five 38 
human enteric viruses and somatic coliphage. Multiple logistic regression and Receiver 39 
Operating Characteristic curve analysis identified a threshold of 3.0 ×10
3
 (3.5-log10) somatic 40 
coliphage plaque forming unit per 100 mL, which corresponded to an increased likelihood of 41 
encountering enteric viruses above the limit of detection (>1.83×10
2
 virus target/100 mL). 42 
Additionally, quantitative microbial risk assessment was executed for famers indirectly reusing 43 
WWTP effluent that met the proposed threshold. The resulting estimated median cumulative 44 
annual disease burden complied with World Health Organization recommendations. Future 45 
studies are needed to validate the proposed threshold for use in Costa Rica and other regions.   46 














Effective wastewater management is crucial to ensure safe direct and indirect water 48 
reuse; nevertheless, few countries have adopted the virus log reduction value management 49 
approach established by the World Health Organization. In this study, we investigated an 50 
alternative and/or complementary approach to the virus log reduction value framework for the 51 
indirect reuse of activated sludge treated wastewater effluent. Specifically, we employed a 52 
well-accepted statistical approach to identify a statistically sound somatic coliphage threshold 53 
value, which corresponded to an increased likelihood of human enteric virus detection. This 54 
study demonstrates an alternative approach to the virus log reduction value framework, which 55 
can be applied to improve wastewater reuse practices and effluent management.  56 













1. Introduction 58 
Conventional activated sludge is an aerobic, secondary wastewater treatment technology 59 
that takes advantage of biological processes to remove organic matter and is commonly used in 60 
low-, middle- and high-income countries (1). Frequently, activated sludge wastewater treatment 61 
plant (WWTP) effluent does not receive additional treatment, even though it is well-known that 62 
pathogen removal can be insufficient for safe water reuse (2–9). This is particularly true for 63 
enteric viruses because traditional activated sludge treatment typically removes viruses 2.02-64 
log10 (1, 10).  Currently, human enteric viruses cause a significant fraction of the disease burden 65 
related to wastewater pollution worldwide. Direct and indirect wastewater reuse (e.g., 66 
agricultural irrigation, recreational activities in contaminated surface waters) represents a public 67 
health risk; thus, the microbial quality of WWTP effluent should be monitored to manage those 68 
risks (11, 12).  69 
Fecal indicator bacteria (e.g., fecal coliform, enterococci, and Escherichia coli) are the 70 
most commonly used indicators for assessing WWTP effluent microbial quality (13). They were 71 
initially introduced as indicators when Salmonella Typhi was the principal pathogen of concern. 72 
Despite their effectiveness for indicating bacterial pathogens, several studies have demonstrated 73 
that fecal indicator bacteria did not correlate with enteric viruses in WWTP effluent (14–17). 74 
Furthermore, high enteric virus concentrations were detected when fecal indicator bacteria 75 
concentrations were low.  76 
While fecal indicator bacteria are not useful viral indicators of wastewater treatment 77 
processes (18, 19), country-specific legislation concerning WWTP effluent reuse and discharge 78 
frequently rely on fecal indicator bacteria (13). No universally accepted viral indicator or criteria 79 
exists to date (10). Some governments now include viral indicators, either human reference viral 80 













pathogens, somatic coliphage or F+ coliphage, to determine WWTP virus reductions 81 
(summarized in (7)). Meta-analyses conducted in wastewater matrices report bacteriophages, 82 
particularly somatic coliphage, as good surrogates of human enteric viruses because of their 83 
similar characteristics, high concentrations, and low-cost methods that distinguish infectious 84 
viruses (10, 20, 21) 85 
Currently, the World Health Organization (WHO) recommends a multiple-barrier 86 
approach to managing WWTP effluent, in which a reference human enteric virus log reduction 87 
value is associated with each treatment process (13). Practitioners define the physical and 88 
chemical conditions that achieve the target virus log reduction value, and then assume that the 89 
log reduction value remains constant if the physical-chemical conditions do not change (22). 90 
While this approach was accepted among experts, most countries in the world have yet to apply 91 
this management approach for a variety of reasons (7). Even though routine monitoring is not 92 
required if physical-chemical conditions remain constant, this log reduction value effluent 93 
management approach has been met with resistance in many countries because it is difficult to 94 
implement into practice given that it is not a threshold value. 95 
Additionally, the reference human enteric virus analyses required to identify the 96 
conditions associated with a target log reduction value are not feasible for many municipal 97 
WWTPs in high-income settings, let alone feasible in middle- and low-income contexts. They 98 
require expertise and sophisticated laboratory equipment, are time consuming, costly, and enteric 99 
virus concentrations are frequently below detectable concentrations (4, 22–24). Furthermore, 100 
these reference pathogen analyses are typically executed using molecular methods, which cannot 101 
distinguish infectious and non-infectious viruses (7, 23, 25). Even though some countries’ 102 
legislation focuses on reference enteric virus log reduction values, somatic and F+ coliphage 103 













have also been used in the log reduction value management framework (10, 11, 26).  Regardless 104 
of the human enteric reference virus or indicator used, the log reduction value management 105 
framework has been criticized for not effectively protecting public health because it focuses on 106 
removal and disregards the variability of human enteric virus concentrations in WWTP influent. 107 
Consequently, additional 2-3-log10 removal can be needed to ensure safe WWTP discharge and 108 
reuse, even if log reduction value targets are met (4). 109 
Prior to the virus log reduction value management approach two decades ago, a somatic 110 
coliphage threshold (3-log10 PFU/100 mL) associated with infectious enterovirus concentrations 111 
was proposed to better manage WWTP effluent discharges (20). However, this threshold value 112 
was never applied to management and needs to be re-calculated because it is based on a non-113 
robust statistical approach and considers just one human enteric virus (27). Given the difficulties 114 
and disadvantages associated with applying the virus log reduction value management approach, 115 
the objective of this study was to determine a statistically-sound, robust somatic coliphage 116 
concentration threshold useful for monitoring WWTP effluents.  117 
To demonstrate this approach, somatic coliphage and enteric viruses were monitored at 118 
five activated sludge WWTPs in the San José Metropolitan Area, Costa Rica. The human enteric 119 
virus included in this study were human enterovirus (EV), hepatitis A virus (HAV), norovirus 120 
genotype I and II (NoVGI and NoVGII), and rotavirus group A (RV) because they are an 121 
important cause of outbreaks and diarrheal illness in Costa Rica (28, 29). Data were analyzed 122 
using the most-accepted, robust statistical methods (multiple logistic regression models and 123 
receiver operating characteristics (ROC) curves (27, 30, 31) to establish a useful threshold that 124 
corresponds to the minimum somatic coliphage concentration associated with increased human 125 
enteric virus detection. Since Costa Rican domestic WWTP effluent is currently managed using 126 













fecal coliform concentration thresholds that vary based upon potential wastewater reuse 127 
activities, fecal coliforms were also monitored simultaneously and similar statistical analyses 128 
were executed to compare the current bacterial indicator with the proposed viral indicator. 129 
Finally, quantitative microbial risk assessment was used to estimate the annual disease burden 130 
associated with indirectly irrigating with WWTP effluent that met the proposed somatic 131 
coliphage threshold. 132 
 133 
2. Materials and Methods 134 
 135 
2.1 Wastewater treatment plant sample collection 136 
A total of 119, 1.5 L influent (n = 60) and effluent (n = 59) samples were collected from 137 
five urban WWTPs located in the San José Metropolitan Area, Costa Rica (Figure 1) All of the 138 
WWTPs are small in size (i.e., treating waste from 123 to 1033 inhabitants and only receive 139 
domestic wastewater) (5, 6, 32). They consist of primary treatment followed by secondary 140 
treatment via conventional activated sludge processes. The WWTP effluents are discharged into 141 
the Virilla River, which are also source water for agricultural irrigation. None of these 142 
wastewater treatment facilities disinfect effluent prior to surface water discharge. Since this 143 
study was executed in a tropical country, there are two seasons: (1) the dry season from 144 
December through April and (2) the rainy season from May through November. In order to 145 
account for seasonal differences in weather and human enteric virus seasonality, grab samples 146 
were collected from each WWTP between 9:00 a.m. and 12:00 p.m. on three consecutive days, 147 
for each of the following months in 2013: March, May, October, and December. All samples 148 
were collected in sterile, amber bottles and maintained at 4 °C until processed. All samples were 149 













analyzed for somatic coliphages and fecal coliform concentrations. Presence/absence analyses 150 
for the following human enteric viruses were carried out on a subset of samples using PCR-based 151 
methods: EV (n = 117), HAV (n = 117), norovirus GI (NoVGI; n = 72) and GII (NoVGII; n = 152 
72); and RV (n = 79).  153 
 154 
2.2 Fecal coliform analyses 155 
Fecal coliforms most probable number (MPN) concentrations were determined by 156 
multiple- tube fermentation (MPN/100 mL) according to Method 9221E within 8 h of collection 157 
(33). Briefly, all samples were inoculated in a series of five tubes with lauryl sulfate broth, in 158 
which the WWTP influent and effluent samples were serially diluted to a concentration of 159 
1:1,000,000 and 1:100,000, respectively, prior to inoculation. Confirmation was executed after 160 
48 ± 4 h of incubation at 35 °C, an inoculum of each tube with bacterial growth and gas were 161 
transferred to EC-MUG broth and were incubated for 24 ± 2 h at 44.5 °C; tubes positive for fecal 162 
coliforms had bacterial growth and gas characteristics. A positive control (E. coli ATCC 25922), 163 
a negative control (Salmonella spp. ATCC 13076), and a blank (containing the dilution buffer as 164 
inoculate) were analyzed alongside all samples. No contamination was observed, and all positive 165 
and negative controls generated positive and negative results, respectively. 166 
 167 
2.3 Wastewater Pre-treament for virus isolation and concentration 168 
 All samples were pre-filtered with a metal sieve (0.15 mm pore) in order to break up 169 
large organic particles. Viruses were concentrated in accordance with, and following, the 170 
Standard Methods for the Examination Water and Wastewater (Section 9510C; (33)). Briefly, the 171 
pre-filtered wastewater sample (1.25 L) was successively filtered through three filters pretreated 172 













with 3% beef extract (pH 7.2; Oxoid
®
, United Kingdom) to remove larger particles and prevent 173 
viruses from sticking to the filters: (1) 47 mm, 80 µm glass fiber filter (13400-47-Q; Sartorius
®
, 174 
Germany); (2) 47 mm, 1.2 µm nitrate cellulose filter (11303-47-N; Sartorius
®
, Germany); and 175 
(3) 47 mm, 0.4 µm acetate cellulose filter (11106-47-ACN; Sartorius
®
, Germany). This filtrate 176 
was divided into two parts: 250 mL for somatic coliphage analyses and 1 L for enteric virus 177 
analyses. With the exception of the somatic coliphage analyses for WWTP effluent, the filtrate 178 
was stored at -70 ºC prior to human enteric virus concentration and WWTP influent somatic 179 
coliphage quantification. 180 
 181 
2.4 Human enteric virus concentration and detection 182 
One liter of filtered WWTP influent and effluent was concentrated using a modified 183 
adsorption-elution method (Method 9510B) (33). Sample pH was adjusted to 3.5 with HCl (0.1 184 
N) and filtered with 47 -mm, 0.2 -nm cellulose acetate filter (1110tr-47N Sartorius
®
, Germany) 185 
to adsorb the viruses onto the filter; approximately three filters were used for each sample in 186 
order to filter the entire 1 -L sample. Subsequently, the viruses were eluted off the filter(s) with 187 
15 mL beef extract 3% pH 9.0. All eluate was collected and precipitated at 4 ºC with PEG8000 188 
and 17.5 g/L NaCl (34). The final virus concentrates (0.5 ml) were stored at -70 °C prior to RNA 189 
purification. The concentration efficiency of this method ranged between 40% - 90% in previous 190 
studies (33, 35). It was also tested with a poliovirus vaccine strain (Sabin vaccine strain), in 191 
which the concentration of the original and concentrated samples were determined using the 192 
Dulbecco plates method (36) with Hep-2 cells. The concentrated sample was 1-log10 more 193 
concentrated in comparison to the original sample (data not shown).  194 













Viral RNA (50 μl) was obtained from the entire final virus concentrate (0.5 ml) using the 195 
NucleoSpin RNA Virus kit (Macherey Nagel
®
, Germany) and cDNA (20 μl) was synthesized 196 
from 8.0 μl viral RNA using the RevertAid
TM 
H Minus First Strand cDNA Synthesis kit with 197 
random hexamers (Thermo Scientific®, USA), both following the manufacturer’s instructions. 198 
Presence/absence analyses for the following human enteric viruses were carried out on a subset 199 
of samples using reverse transcriptase polymerase chain reaction (RT-PCR)-based methods and 200 
previously published assays and conditions (Table 1; (37–40): enterovirus (EV; n = 117), 201 
hepatitis A virus (HAV; n = 117), norovirus GI (NoVGI; n = 72) and GII (NoVGII; n = 72), and 202 
rotavirus group A (RV; n = 79). Presence-absence human enteric virus data were generated in 203 
this study because previous studies demonstrated a better correlation between enteric virus 204 
presence/absence and coliphages in comparison with correlations with quantitative enteric virus 205 
data (27, 41). All RT-PCR-based analyses were executed using Master Mix 2X (Fermentas®, 206 
USA) with a final reaction volume of 25 μL.  207 
For the end-point RT-PCR assays (EV and HAV), the Applied BioSystem® Veriti 9902 208 
thermocycler was used. A sample was identified as positive when PCR products with the 209 
anticipated size (EV, 113 bp; HAV, 266 bp) were visualized using 2% agarose gel 210 
electrophoresis with GelRed®. For NoVGI, NoVGII, and RV presence/absence was determined 211 
using RT-quantitative PCR (RT-qPCR) with a StepOne Real-Time PCR thermocycler (Applied 212 
Biosystems®). A sample was identified as positive if the Cq value was less than 35. For samples 213 
with a Cq value greater than 35 and less than 40, the sample was re-run and all samples with 214 
mean Cq values ≤ 35 were classified as positive.  215 
In addition to a negative control (sterile water), the following positive controls, specific to 216 
each assay, were used for each instrument run: RV-, NoVGI-, and NoVGII-positive fecal 217 













samples (Costa Rican National Children’s Hospital), the Sabin 1 (NIBSC 1/528) vaccine strain 218 
for EV (University of Costa Rica, Department of Microbiology, Virology Section), and HAX-70 219 
strain for HAV (University of Costa Rica, Department of Microbiology, Virology Section). All 220 
positive controls yielded positive results and all negative controls were negative. The enteric 221 
virus theoretical process detection limit (copies/100 mL)
 
was back-calculated using the following 222 
equation, which took into account the efficiency published for each step in the molecular 223 
analyses as well as the concentration methods used (Eq. 1): 224 




















𝑉5 × 𝐸3 
 
where c equals copies that could be detected per RT-qPCR reaction (i.e., lowest copy number 225 
detected divided by 2 (difference between double-stranded standard curve material and single-226 
stranded viral RNA)); v1 equals the volume of cDNA added to the qPCR reaction (5 µl); V1 227 
equals the total volume of cDNA synthesized (20 µl); E1 equals the worst-case RT efficiency 228 
previously reported (19%; (42)); v2 equals the volume of RNA in the RT reaction (8 µl); V2 229 
equals the total volume of RNA purified (50 µl); E2 equals the worst-case viral RNA purification 230 
efficiency (90%; (43));  v3 equals the volume of  PEG concentrate that RNA was purified from 231 
(500 µl); V3 equals the total volume of PEG concentrate (500 µl); v4 equals the eluate volume 232 
that was PEG concentrated (45 mL); V4 equals the total volume of eluate (45 mL); V5 equals the 233 
total volume of wastewater (1000 mL); and E3 equals the estimated virus concentration 234 
efficiency (40%; (35)). The limit of detection for the assays could have been as few as 10 copies 235 
(J. Nordgren, personal communication) and great as 1,000 copies (37, 38). Since the limit of 236 
detection of each assay was not tested in this study, the limit of detection (c) was defined as 10 237 
copies and 1,000 copies. Thus, the theoretical process limit of enteric virus detection for any 238 
given assay was estimated to range from 183 virus copies/100 mL to 18,300 copies/100 mL. 239 














2.5 Somatic coliphage quantification  241 
Somatic coliphage concentrations were determined according to Methods 9924B Somatic 242 
Coliphage Assay and 9924E Single-Agar-Layer Method with modifications: 250 mL sample 243 
volumes were filtered with 0.2 μm filter (cellulose acetate, 11107- 91 47N Sartorius
®
, Germany) 244 
that was pretreated with 3% beef extract pH 7.2 (33, 44). Somatic coliphage concentrations were 245 
identified in WWTP effluent samples using single-layer plaque assay (undiluted sample) and in 246 
WWTP influent samples using double-layer plaque assay (1:10,000 serial-dilution of sample). 247 
Analyses used the host strain E. coli ATCC 13706. Positive (PhiX174 ATCC 13706-B1 phage) 248 
and negative (buffer only) controls were run alongside samples. No contamination was observed, 249 
and all controls gave anticipated results. 250 
 251 
2.6 Data analyses: statistics and indicator concentration threshold evaluation 252 
Descriptive statistics (mean and standard deviation) and comparative (two-group 253 
comparisons) analyses were executed using R’ Version 3.5.3 (www.rproject.org) with the 254 
appropriate methods for non-parametric uncensored, as well as right-, and left-censored data 255 
from the NADA package (45).  Mean and standard deviation were calculated for somatic 256 
coliphages for WWTP influent, and excluded WWTP influent concentrations that were 5-log10 257 
PFU/100 mL below the average (n = 31). These data were excluded because somatic coliphage 258 
were analyzed with culture-based analyses that were likely inhibited by high concentrations of 259 
household disinfectants (46).  260 
The mean and standard deviation were estimated using the Kaplan Meir method for the 261 
following censored data: somatic coliphage WWTP effluent, and fecal coliforms WWTP influent 262 













and effluent. All somatic coliphage WWTP effluent concentrations below the detection limits 263 
(<1 PFU/ 100 mL; e.g. left-censored) were conservatively censored to 0.9 PFU/ 100 mL (n = 8). 264 
All fecal coliforms concentrations greater than the method detection limits (e.g., right-censored) 265 
were censored to one plus the highest detectable concentration (i.e., > 8.2-log10 MPN/ 100 mL 266 
for WWTP influent (n = 22) and > 6.2-log10 MPN/ 100 mL for WWTP effluent (n = 11)). The 267 
Peto-Prentice test is a non-parametric analysis that is appropriate for censored data. It was used 268 
to test the null hypotheses that there was no significant difference in indicator concentrations 269 
(somatic coliphage or fecal coliform) between WWTP influents, WWTP effluents, and WWTP 270 
influent and effluents combined.  271 
In order to calculate an indicator threshold concentration that corresponds to human 272 
enteric virus detection, multiple logistic regression models were created to determine the 273 
statistical significance and association between each indicator and any human enteric virus 274 
detection for WWTP influent and effluent (41). The positive classification for human enteric 275 
virus detection was based upon the detection of any of the five viruses, which reflects the 276 
existence of a public health risk if any one of the viruses are detected, and was previously 277 
recommended for this type of analysis (27). The multiple logistic regression model equation was 278 




) = 𝛽0 + 𝛽1𝜒1 + 𝛽2𝜒2 
where p was human enteric virus detection (PCR positive/negative; dependent and dichotomic 280 
variable), β0 was the intercept, β1 and β2 were the regression parameters, χ1 was the indicator 281 
(either somatic coliphage or fecal coliforms) concentration, and χ2 was the dichotomic variable 282 
for season. Analyses were conducted for WWTP influent and effluent separately. The specific 283 
WWTP was a controlled factor in the model. Chi-square and unpaired two-sample t-test analyses 284 













were used to identify significant (p < 0.05) differences between the multiple logistic regression 285 
model parameters. Since the WWTP influent multiple logistic regression models did not yield 286 
statistically significant relationships; subsequent analyses were conducted only on the WWTP 287 
effluent models.   288 
For each indicators’ WWTP effluent multiple logistic regression model, the area under 289 
ROC curves were estimated in order to measure the regression model’s ability to discriminate 290 
between effluent samples with and without the detection of any human enteric virus pathogens. 291 
The ROC curve is a plot of sensitivity (true-positive rate, y-axis) and specificity (false-positive 292 
rate, x-axis) of the logistic regression model and it was used predict human enteric virus 293 
detection  (any of the five human enteric viruses) in effluent samples. The area under the ROC 294 
curve, also known as ROC/AUC value, is a precision estimate expressed as a continuous value 295 
within a 0 to 1 range. The higher the ROC/AUC value, the more precise the logistic prediction 296 
model.  The ROC/AUC value and the area under the ROC curve are among the most objective 297 
methods for the evaluation of binary classifiers (27, 31) and have previously been used to 298 
predict enterovirus presence based upon somatic coliphage concentrations in recreational 299 
waters (47). Multiple logistic regression and ROC curve analyses (27, 47) were executed using 300 
STATA software version 13 (48). 301 
The recommended cut-off points for ROC/AUC were used in this study to determine 302 
the logistic regression model’s discrimination ability: 0 to 0.5, null discrimination; 0.7 to 0.8, 303 
acceptable discrimination; 0.8 to 0.9, excellent discrimination; and 0.9 - 1.0, exceptional 304 
discrimination (31, 49). The multiple logistic regression model’s discrimination ability must be  305 
at least acceptable (ROC/AUC ≥ 0.7) in order to identify a statistically-sound WWTP effluent 306 
indicator threshold concentration associated with an increased probability of human enteric 307 













virus detection. Additionally, the indicator concentration parameter in the multiple logistic 308 
regression model must have a significant association (p-value <0.05) with the detection of any 309 
human enteric virus. The WWTP effluent somatic coliphage multiple regression model was 310 
the only model to comply with the aforementioned criteria. The somatic coliphage threshold 311 
concentration was identified at the concentration associated with the greatest sensitivity and 312 
specificity in the ROC analysis. 313 
The calculated somatic coliphage threshold concentration was evaluated for its ability 314 
to identify human enteric virus PCR-positive WWTP effluent samples (27, 31).  True-positive 315 
(i.e., PCR-positive for any of the human enteric viruses analyzed and somatic coliphage 316 
concentration equal to or above the threshold), true-negative (i.e., PCR-negative for any of the 317 
human enteric viruses analyzed and somatic coliphage concentration below the threshold), 318 
false-positive (i.e., PCR-negative for any of the human enteric viruses analyzed and somatic 319 
coliphage concentration equal to or above the threshold), and false-negative (i.e., PCR-positive 320 
for any of the human enteric viruses analyzed and somatic coliphage concentration below the 321 
threshold) samples were calculated. Finally, the positive predictive value (i.e., probability of 322 
being PCR-positive for any of the human enteric viruses analyzed and the sample exceeded the 323 
indicator threshold) and the negative predictive value (i.e., probability of being PCR-negative 324 
for any of the human enteric viruses analyzed and the sample was below the indicator 325 
threshold) were calculated. 326 
2.7 Quantitative microbial risk assessment for indirect reuse of wastewater treatment plant 327 
effluent meeting the somatic coliphage threshold 328 
In order to understand the health risks associated with the proposed somatic coliphage 329 
threshold, quantitative microbial risk assessment was executed for a hypothetical wastewater 330 













reuse scenario using EV, HAV, and NoVGI as reference pathogens. RV was not included in 331 
this analysis because adults are not susceptible to RV (50). NoVGII was not included because 332 
no dose-response curve currently exists (62). The annual disease burden for an adult farmer 333 
indirectly irrigating with WWTP effluent meeting the somatic coliphage threshold was 334 
estimated in ‘R’ Version 3.5.3 (www.rproject.org). For each model parameter defined as a 335 
distribution, a set of 10,000 random values was used to calculate the annual disease burdens in 336 
order to account for the uncertainty and variability associated with the model parameters.  337 
First, daily exposure was defined for an adult farmer indirectly using the WWTP effluents 338 
from this study to irrigate crops, using the following equation (Eq. 3) for each enteric virus and 339 
parameter values/distributions (Table 2): 340 
𝑑𝑜𝑠𝑒 = 𝑣 × (
𝑐 ×  𝑒−𝑘𝑑𝑡
(1 + 𝑑)
)   
where c is the WWTP effluent virus concentration when somatic coliphage concentrations are 341 
below the threshold, v is the volume of water accidentally ingested by the adult farmer 342 
irrigating on one day, d is the dilution factor from the WWTP effluent mixing in the river, kd is 343 
the mean virus decay rate constant, and t is decay time (i.e., the time the virus was in the river 344 
prior to irrigation). Similar to other studies, it was assumed that 1 mL of water was 345 
accidentally ingested per day of exposure (51, 52). The infectious enteric virus concentration 346 
in the WWTP effluent was defined as a uniform distribution between 0 and the maximum 347 
theoretical process limit of detection. Virus decay followed a first-order decay equation (53), 348 
using mean decay rates determined from experiments with similar conditions to those in the 349 
Virilla River (54–56). The WWTP effluent in this study is indirectly reused at distances 350 
ranging from 1 m to 3 km from WWTP discharge; thus, decay time was defined as a uniform 351 
distribution between 0 and 1 days (57). Since the dilution factor can vary greatly over time and 352 













by season, the dilution factor was defined as a uniform distribution between a conservative 353 
dilution factor (99:1) and a maximum dilution factor (50,000:1) (53).   354 
 The daily probability of infection (Pinf) for each virus was then calculated using the 355 
dose previously calculated (Eq. 3) and the previously published dose-response curves and 356 
parameters distributions (Table 2). Briefly, the exponential dose-response curve was used for 357 
EV, which was derived from a study with pigs and porcine enterovirus type 7 (58). The 358 
exponential dose-response curve was also used for HAV, derived from a HAV human 359 
challenge study (59). For NoVGI, the fractional Poisson dose-response curve, derived from 360 
NoVGI human challenge studies, was used (60). Since there is no agreement among the 361 
scientific community with respect to NoV dose response parameters, they were described as 362 
recommended (62). The NoVGI aggregation factor (µ) was described as distribution ranging 363 
from minimum to maximum aggregation. The NoVGI genetically susceptible fraction of the 364 
population (p) was adjusted to represent Costa Rica’s demographics (61, 62).  365 
Subsequently, the daily probability of illness (Pill) for each virus was calculated with 366 
the following equation (Eq. 4):  367 
𝑃𝑖𝑙𝑙 =  𝑃𝑖𝑛𝑓 × 𝑀 
where Pinf is the probability of infection previously calculated and M is the morbidity ratio 368 
(Table 2 (50, 51, 59, 63–66)). The annual risk of illness (Pa) for each virus was then calculated 369 
as follows (Eq. 5):  370 
𝑃𝑎 = 1 − (1 −  𝑃𝑖𝑙𝑙)
𝑛 
where Pill is the daily risk of illness (Eq. 4) and n is the number of days adult farmers are 371 
exposed each year. Similar to other wastewater reuse irrigation studies, it was assumed that 372 
farmers irrigated 75 days per year (51, 65, 66). Finally, the annual disease burden (DB; daily 373 













life adjusted years (DALYS)/person) for each virus was estimated as follows (Eq. 6): 374 
𝐷𝐵 =  𝑃𝑎  × 𝐵 × 𝑆𝑓 
where Pa is the annual risk of illness (Eq. 5), B is the disease burden per case of illness, and Sf 375 
is the susceptible fraction of the population (Table 2). The disease burden per case of illness 376 
(B) was not available for Costa Rica (middle-income country); thus, it was defined as a 377 
uniform distribution with minimum and maximum values identified for developing and 378 
developed countries (50, 67–69). The NoV susceptible fraction of the population (Sf) was 379 
defined as a uniform distribution for the Costa Rican demographic (61, 62). The EV 380 
susceptible fraction of the population (Sf) was assumed to be 1 given high EV diversity (51). 381 
The HAV susceptible fraction of the population was 0.717, as defined by seroprevalence in 382 
adult Costa Rican population (28). Finally, the cumulative annual disease burden per person 383 
from the three reference viruses was calculated by adding together the annual disease burden 384 
(DB) for each virus. Since the dose calculation usually has the most significant influence on 385 
model outputs (70) this quantitative microbial risk assessment’s sensitivity to the exposure 386 
assessment (Eq. 3) input parameters was tested by calculating the Spearman rank order 387 
coefficients between the simulated input parameters and the estimated cumulative annual 388 
disease burden (α = 0.05).   389 
 390 
3. Results and Discussion 391 
 392 
3.1 Fecal coliforms and somatic coliphage in untreated wastewater 393 
For the five WWTPs investigated during this study, the mean (+/- standard deviation) 394 
fecal coliform influent concentration was estimated as 6.8- ± 6.8-log10 MPN/ 100 mL, similar to 395 













those summarized in the literature (71). The mean (+/- standard deviation)  somatic coliphage 396 
influent concentration was 8.7- ± 9.0-log10 PFU/ 100 mL, which is 3-log10 PFU/ 100 mL greater 397 
than the mean concentration calculated in a recent global meta-analysis (Figure 2) (11). It is 398 
important to note that this recent meta-analysis did not include any Latin American countries and 399 
identified statistically significant differences between the geographical locations studied (11). 400 
The mean somatic coliphage influent concentrations reported in this study are more comparable 401 
to those in Argentina and Colombia, which are likely more similar to those in Costa Rica due to 402 
geographic location and water usage (72). 403 
 404 
3.2 Fecal coliforms and somatic coliphage highly variable in treated wastewater 405 
Both fecal coliforms and somatic coliphage concentrations were highly variable in the 406 
WWTP effluent studied, with mean and standard deviations estimated as 6.1- ± 6.6-log10 MPN/ 407 
100 mL and 3.2- ± 3.1-log10 PFU/ 100 mL, respectively (Figure 2). The effluent fecal coliforms 408 
and somatic coliphage concentrations were similar to other WWTP studies (3, 20, 73, 74). 409 
Variability in the WWTP operational conditions (e.g., concentration of mixed liquor suspended 410 
solids, temperature, and biochemical oxygen demand (BOD)) are likely responsible for the 411 
indicator variability observed in this study (10, 72, 75, 76). Globally, fecal coliforms and somatic 412 
coliphage mean concentrations were significantly lower in the effluent in comparison to the 413 
influent (p<0.0001). However, with respect to WWTPs individually, mean fecal coliforms and 414 
somatic coliphage concentrations were lower in effluents than in influents at three of the five 415 
WWTPs (p = 6.0×10
-6 
to 0.02) and all five of the WWTPs (p = 6.0×10
-7 
to 0.04), respectively. 416 
Globally, the fecal coliforms and somatic coliphage mean (+/- standard deviation) log reduction 417 













values were 0.99- ± 1.33-log10 and 2.70- 2.60-log10, respectively, and coincided with ranges 418 
previously reported  (1).  419 
 420 
3.3 Human enteric viruses frequently detected in (un)treated wastewater 421 
 Human enteric viruses (EV, HAV, NoVGI, NoVGII, or RV) were detected in WWTP 422 
influent and effluent at variable frequencies (Table 3). No statistical difference with respect to 423 
the frequency of human enteric virus detection was found between the WWTP influent and 424 
effluent (p > 0.45). RV was the most frequently detected in both influent and effluent samples 425 
(47% and 39%, respectively; Table 3), followed by NoV (GI and GII; 39% and 36%, 426 
respectively). Globally, NoVGI was detected two times more frequently than NoVGII. Less than 427 
25% of the samples were positive for EV and less than 10% of the samples for HAV. It is 428 
important to mention that EV and HAV were analyzed in 117 out of 119 water samples; 429 
meanwhile, RV and NoV were analyzed in two-thirds of the samples (n = 79 and 80, 430 
respectively). Similar to all PCR-based analyses, it is possible that samples with undetected 431 
viruses had virus concentrations below the method detection limits or that inhibitors decreased 432 
RT-PCR efficiency (24). Additionally, a mixture of end-point and qPCR assays were effectively 433 
used in this study because improved resources were not logistically available. The lack of 434 
available resources is common in middle- and low-income countries because funds are limited, 435 
and supplies are often more expensive as well as difficult to import. When possible, future 436 
studies should use just one type of PCR-based analysis.   437 
 The RV and NoV data presented in this study corroborate with RV and NoV 438 
epidemiologies in Central and South American countries, in which they are present throughout 439 
the year and peak during the dry season (December – May) (77–79). Similar to our study, 440 













NoVGI has been previously quantified in Costa Rican wastewater year-round, with peaks in the 441 
dry season, at a WWTP in the Province of Puntarenas; in contrast, RV was the most frequently 442 
detected virus in our study and the lowest quantified in Symonds et al. (80). The difference in 443 
RV prevalence between the two studies is likely due to RV epidemiology in Costa Rica, where 444 
RV infection is more frequent in the Greater Metropolitan Area compared to coastal regions 445 
(such as the WWTP in Puntarenas) (81). With respect to EV, detection was very low (22%) in 446 
influent and effluent in comparison to the USA (e.g., > 92% (25)). This difference may be due to 447 
differences in epidemiology and/or methods between the two studies; however, it is difficult to 448 
ascertain the origin of these differences because Central American EV epidemiology data is 449 
limited. 450 
 451 
3.3 Fecal coliforms do not correlate with human enteric virus detection and no threshold 452 
identified 453 
Multiple logistic regression models were used to analyze the statistical relationship 454 
between fecal coliform concentrations and the detection of human enteric viruses at influent 455 
and effluent wastewater samples. The estimated parameters from this logistic regression model 456 
were -3.47×10
-07
 (p = 0.258) for fecal coliforms concentrations and 0.8881 (p = 0.297) for 457 
dry/rainy season. According to the model, fecal coliforms do not correlate with human enteric 458 
virus detection in WWTP influent or effluent (OR = 0.99, p = 0.26). Despite the lack of 459 
relationship between fecal coliforms and human enteric viruses detection, ROC analysis was 460 
used to estimate a possible fecal coliform concentration associated with the detection of any of 461 
the five human enteric viruses analyzed (i.e., to identify an appropriate maximum fecal 462 
coliform concentration associated with increased human enteric virus detection). The ROC 463 













analysis for fecal coliforms and human enteric virus detection did not have acceptable 464 
precision (ROC/AUC= 0.64). These findings corroborate with previous studies that did not 465 
identify correlations between fecal coliform concentrations and human enteric virus detection 466 
(10, 20, 41, 82). 467 
 468 
3.4 Somatic coliphage correlate with human enteric virus detection and a threshold was 469 
identified 470 
Multiple logistic regression models were also used to analyze the statistical relationship 471 
between somatic coliphage concentrations (PFU/ 100 mL) and human enteric virus detection 472 
in WWTP influent and effluents. For the WWTP influent, the estimated multiple logistic 473 
regression model parameters were 3.98×10
-10
 (p = 0.074) for somatic coliphage concentration 474 
and 0.5606 (p = 0.035) for dry/rainy season. WWTP influent had a 75% probability of being 475 
positive for at least one of the human enteric viruses studied during the dry season in 476 
comparison to the rainy season (OR = 1.75, p = 0.035). Additionally, a significant correlation 477 
between somatic coliphage concentrations and human enteric virus detection was identified in 478 
WWTP effluent (OR = 1.00, p = 0.01), which was similar to those previously described by (3, 479 
10, 83). For the WWTP effluent, the estimated multiple logistic regression model parameters 480 
were -0.0004 (p = 0.006) for somatic coliphage concentration and 0.8881 (p = 0.297) for 481 
dry/rainy season. It is important to note that season was not a significant predictor of human 482 
enteric virus detection in WWTP effluent (OR = 2.43, p = 0.297). 483 
In order to determine an appropriate somatic coliphage concentration associated with 484 
an increased probability of human enteric virus detection, ROC analysis was used to estimate 485 
the somatic coliphage concentration associated with human enteric virus detection (i.e., any of 486 













the five viruses) in WWTP effluent. The area under the ROC curve (AUC) was 0.7 (Figure 3); 487 
thus, it had an acceptable discrimination ability. The sensitivity and specificity curves intersect 488 
near the 0.526 probability cutoff, where the highest specificity (75%) and sensibility (54%) 489 
were found when the somatic coliphage concentration was 3.5-log10 PFU/ 100 mL (p = 0.526). 490 
Thus, this somatic coliphage threshold (3.5-log10 PFU/100 mL) was the concentration most 491 
likely associated with a lack of human enteric virus detection. 492 
This somatic coliphage threshold was evaluated for its ability to identify human enteric 493 
virus PCR-positive WWTP effluent samples by calculating the Positive and Negative Predictive 494 
Values (31).  The frequencies of true-/false-positives and true-/false-negatives were calculated 495 
for each enteric virus type (Table 4), which were used to calculate the Positive and Negative 496 
Predictive values. Positive Predictive Value was 46%; therefore, 46% of samples had somatic 497 
coliphage concentrations above the threshold and human enteric viruses were detected. The 498 
Negative Predictive Value was 33%; thus, 33% of samples had somatic coliphage concentrations 499 
less than the threshold and no human enteric viruses were detected. Using this threshold, only a 500 
34.5% of the samples were classified as false-negative and would represent a possible human 501 
health risk (Table 4). Overall, 65.6% of WWTP effluent samples were safely classified using the 502 
proposed somatic coliphage threshold.  503 
Similar to this study, low or undetectable human enteric virus concentrations were 504 
measured in WWTP effluent when somatic coliphage concentrations were below 3.5-log10 PFU/ 505 
100 mL (3, 20, 73, 74, 83, 84). Nevertheless, it is important to note that the results of this study 506 
are directly dependent on the efficiencies and detection limits of the methods used. It is possible 507 
that the somatic coliphage threshold would be different if different methods (e.g., virus 508 
concentration, RNA extraction) were used or if additional/fewer human enteric viruses had been 509 













analyzed. Furthermore, this study does not take into consideration the detection of infectious 510 
human enteric viruses. Future studies are needed to explore and confirm the somatic coliphage 511 
threshold identified in this study. Specifically, studies are needed that take into consideration 512 
human enteric virus infectivity. It is also important to analyze how the use of different methods 513 
may or may not influence the somatic coliphage threshold identified. Interestingly, the somatic 514 
coliphage threshold identified in this study is similar to the threshold previously proposed two 515 
decades ago (3-log10 PFU/ 100 mL), even though this study were executed using different 516 
statistical and virus methods, only analyzed human EV, and used cell-culture methods (20). 517 
 518 
3.5 Annual disease burden for indirectly reusing wastewater effluent below the proposed 519 
threshold 520 
Quantitative microbial risk assessment was used to estimate the EV, HAV, NoVGI, as 521 
well as cumulative (all three viruses) annual disease burden for an adult farmer irrigating 522 
indirectly (75 days per year) with WWTP effluent below the proposed somatic coliphage 523 
threshold. The median cumulative annual disease burden per adult farmer was 2.52 × 10
-5
 524 
DALYs (Figure 4), which is less than the recommendation of 10
-4 
(11, 85). EV contributed the 525 
most to the cumulative annual disease burden, followed by HAV and NoVGI. The exposure 526 
assessment parameter sensitivity analysis indicated that the daily volume ingested (ρ = 0.479, p = 527 
2.2 × 10
-16
), WWTP effluent infectious enteric virus concentrations (ρ = 0.471, p = 2.2 × 10
-16
), 528 
and the dilution factor (ρ = -0.466, p = 2.2 × 10
-16
) were most influential on the cumulative 529 
annual disease burden estimates in comparison to the decay-related variables (0.102 ≤ | ρ | ≤ 530 
0.231; p < 2.2 × 10
-16
). Furthermore, the NoVGI decay rate did not significantly correlate with 531 
the cumulative annual disease burden (ρ = -0.017, p = 0.087).  532 













Based upon the sensitivity analysis results, it is likely that the cumulative annual disease 533 
burdens may increase or decrease markedly if the estimated daily volume ingested and/or 534 
WWTP effluent infectious enteric virus concentrations were higher or lower, respectively. In 535 
order to incorporate uncertainty and variability in this study, WWTP effluent infectious enteric 536 
virus concentrations were defined as a uniform distribution between 0 and the maximum 537 
theoretical process limit of detection. It was assumed that all viruses were infectious; thus, it is 538 
possible that the cumulative disease burden calculated overestimated risk. Additionally, the 539 
cumulative disease burden calculated could underestimate the actual risk if the theoretical 540 
process limit of detection was greater than the maximum value estimated. Nevertheless, the 541 
theoretical process limit of detection took into account losses associated with virus concentration 542 
and detection. 543 
Since Costa Rican culture lacks habits associated with additional hand-mouth contact 544 
(e.g., Bolivia, chewing coca leaves), a point value traditionally used in quantitative microbial risk 545 
assessment was used even though it can impact model output (51). Similarly, it was difficult to 546 
identify the dilution factor of the WWTP effluent entering the river due to constant fluctuations 547 
in river flow rates and volume. Consequently, this parameter was defined as a distribution 548 
between a conservative (99:1) and maximum (50,000:1) assumption (53). If the dilution factor 549 
was greater, then the cumulative annual disease burden estimates would be much lower. Finally, 550 
cumulative annual disease burden would be greatly affected if the number of days farmers 551 
irrigated indirectly with WWTP effluent were greater or less than the assumed 75 days. 552 
While quantitative microbial risk assessment is a useful tool, it is based upon assumptions 553 
that may or may not reflect reality. Consequently, this quantitative microbial risk assessment 554 
incorporated the use of parameter distributions to account for this uncertainty and variability. 555 













Nevertheless, it is important to recognize that the dose-response curves and parameter 556 
distributions may not reflect realistic human populations, which can highly influence model 557 
outputs (53, 70). This is particularly true for EV, which is based upon a non-human model (51, 558 
58), and NoVGI because there is no agreement on which parameters are most appropriate (62). 559 
Point values were also used for certain parameters when preferred values were previously 560 
identified in other studies. Additionally, data from other contexts were used when contextualized 561 
data were lacking. Similar to other studies, it is likely that these assumptions influenced the 562 
model output (51,53, 70). Although wastewater contains a wide-variety of disease-causing 563 
viruses, it is not possible to estimate the disease burden of all pathogens given the lack of 564 
disease-related and dose-response data. Consequently, this study incorporated three reference 565 
pathogens to calculate the cumulative annual disease burden associated with indirect wastewater 566 
reuse with WWTP effluent meeting the somatic coliphage threshold. 567 
 568 
3.6 Implications for activated sludge WWTP effluent management 569 
 As far as we know, this is the first report of a statistically sound somatic coliphage 570 
threshold estimation for WWTP effluent management. The use of a somatic coliphage threshold 571 
of 3.5-log10 PFU/ 100 mL is an affordable alternative and/or complement to the  virus log 572 
reduction value multiple barrier system approach, and if implemented, could improve WWTP 573 
effluent management in resource-limited regions that have been resistant to the aforementioned 574 
approach. Thus, compliance with this threshold would assure lower enteric virus concentrations 575 
discharged into nearby rivers with downstream uses in agriculture.  576 
Additionally, the indirect reuse of WWTP effluent meeting the proposed somatic 577 
coliphage threshold was associated with a median cumulative annual disease burden that 578 













complies with the WHO recommendation (13, 85). Given the potential of the proposed somatic 579 
coliphage to improve activated sludge WWTP effluent management, further research is 580 
warranted to validate, improve, and optimize this threshold for use in Costa Rica. Future 581 
investigations should include improved disease burden estimates that contain the most context-582 
appropriate data possible, especially with respect to the exposure assessment parameters. 583 
Additional research is also needed to validate the way in which such a threshold should be 584 
implemented (e.g., geometric mean, single measurement, 95% percentile) to ensure improved 585 
wastewater effluent management, and ultimately better protect public health. Finally, the 586 
statistical approach presented here can be implemented in other regions to determine a logical 587 
and feasible metric to improve upon existing WWTP discharge legislation.  588 
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Table 1. RT-PCR and RT-qPCR assays used to detect enterovirus, hepatitis A, rotavirus group A, and norovirus genotypes I and II. 
 




EV 5’ Non 
coding 
region 
EV1: 5’ ATTGTCACCATAAGCAGCCA 3’ 
EV2: 5’ TCCGGCCCCTGAATGCGGCTAATCC 3’ 
EV3: 5’ 
ACACGGACACCCAAAGTAGTCGGTTCC 3’ 
EV4: 5’ TCCGGCCCCTGAATGCGGCTAATCC3’ 
PCRI: EV1/EV2 
Activation cycle (95 ºC 5 min) 
30 cycles: 95 ºC 45s, 55 ºC 45 s, 
and 70 ºC 45s 
PCRII: EV3/EV4 
Activation cycle (95 ºC 5 min) 
30 cycles: 95 ºC 45s, 55 ºC 45 s, 
and 70 ºC 45s 
EV1: 6.1 mM 
EV2: 7.6 mM 
EV3: 8.2 mM 




HA1: 5’ TTGCTCCTCTTTATCATGCTATG 3’ 
HA3: 5’ TGGTTAAATCTAATGGTCCTCTATA 3’ 
Activation cycle (95 ºC 5 min) 
40 cycles: 95 ºC 30s, 46 ºC 30 s, 
and 70 ºC 30s 
HA1: 8.7 mM 
HA3: 9.6 mM 
(38) 











RV NSP-3 ROTAS1: 5’ ACCATCTTCACgTAACCCTC 3’ 
ROTAS2: 5’ ACCATCTACACATGACCCTC 3’ 




Activation cycle (95 ºC 5 min) 












ORF1 NVG1F: 5’CGYTGGATGCGNTTCCATGA 3’ 
NVG1R: 5’ GTCCTTAGACGCCATCATC 3’ 
G1-prob: [6FAM]-AGATYGCGRTCYCCTGTCCA-
[BHQ1] 
Activation cycle (95 ºC 5 min) 
40 cycles: 95 º 15 s, 56 ºC 60 s 
NVG1F: 0.2 pM 






ORF1 NVG2F: 5’ATGTTYAGRTGGATGAGRTTYTC 3’ 
COG2R: 5’ TCgACgCCATCTTCATTCACA 3’ 
G2-prob: 
Activation cycle (95 ºC 5 min) 
40 cycles: 95 º 15 s, 56 ºC 60 s 
NVG2F: 0.2 pM 
COG2R: 0.2 pM 
G2-prob: 0.2 
(21) 



































Table 2. Quantitative microbial risk model parameter values/distributions, and dose-
response equations. 
 
Parameter Units Value or distribution Reference 
Virus concentration in WWTP 
effluent (c) 
Virus/1 mL uniform(0, 182) This study. 
Volume of water ingested (v) mL 1 (51, 52) 
Dilution factor (d) proportion uniform(99,50000) (53) 
Time in river (t) day uniform(0,1) (53, 57) 
Mean decay rate (kd) day-1   
enterovirus  0.028 (55) 
hepatitis A  0.22 (54) 
norovirus genotype I  0.08 (56) 
Dose-response    
enterovirus Exponential 𝑃𝑖𝑛𝑓 = 1 − 𝑒−𝑑 ×𝑘 
k = uniform(0.00291, 0.00562) 
(58) 
hepatitis A Exponential 𝑃𝑖𝑛𝑓 = 1 − 𝑒−𝑑 ×𝑘 
k = uniform(0.00005871, 0.001191) 
(59) 
norovirus genotype I Fractional 
Poisson 
𝑃𝑖𝑛𝑓 = 𝑃 × [1 − 𝑒−𝑑𝜇  ] 
P = uniform(0.87, 1) 
µ =  uniform(1, 1106) 
(60 - 62) 
Morbidity Ratio (M)  











Menterovirus median 0.9 (50) 
Mhepatitis A  uniform(0.25, 0.92) (59, 63) 
Mnorovirus  uniform(0.3, 1) (64) 
Total annual days of irrigation  days/farmer 75 (51, 65-66) 
Disease burden per illness (B) DALYS/case 
of illness 
  
Benterovirus  uniform(0.0024,0.0150) (68, 69) 
Bhepatitis A  uniform(0.0761, 0.191) (50) 
Bnorovirus  uniform(0.000371, 0.00623) (67) 
Susceptible fraction of population 
(S) 
proportion   
Senterovirus  1 (51) 
Shepatitis A  0.717 (28) 
Snorovirus  uniform(0.87,1.00) (61, 62) 
 
 











Table 3. Positive samples (%) for human enteric viruses in wastewater influent and effluent 
from five activated sludge wastewater treatment plants in Costa Rica, 2013. 
 
Variable 
Influent Effluent Total 
p* (No. positives / 
No. samples) (%) 
(No. positives / 
No. samples) (%) 
(No. positives 
/ No. samples) 
(%) 
Any viral pathogen** 32/60 (53%) 31/59 (53%) 63/119 (53%) 0.93 
Enterovirus 13/59 (22%) 13/58 (22%) 26/117 (22%) 0.96 
Hepatitis A 5/59 (8%) 3/58 (5%) 8/117 (7%) 0.48 
Rotavirus 18/38 (47%) 16/41 (39%) 34/79 (43%) 0.45 
Norovirus GI  16/38 (39%) 13/34 (36%) 29/72 (37%) 0.74 
Norovirus GII 9/38 (24%) 4/34 (12%) 13/72 (18%) 0.19 
All Norovirus 16/41 (39%) 14/39 (36%) 30/80 (37%) 0.77 
 
* Person Chi-square results for differences in detection of pathogens. 
** Total number of water samples positive for any pathogenic virus. 
 











Table 4. Relationship between human enteric virus detection and somatic coliphage 
concentrations above calculated threshold in wastewater treatment plant (WWTP) 
effluent. 
Human Enteric Virus* 










Enterovirus (n=58) 6 (10.3) 22 (37.9) 7 (12.1) 23 (39.7) 
Hepatitis A Virus (n=58) 0 (0) 28 (48.3) 3 (5.2) 27 (46.6) 
Rotavirus (n=41) 6 (14.6) 23 (56) 10 (24.4) 12 (29.3) 
Norovirus (n=40) 6 (15.8) 13 (31.7)  7 (18.4) 14 (36.8) 
Any virus (n=58) 13 (22.4) 15 (25.9) 20 (34.5) 10 (17.2) 
* Some samples were positive for more than one human enteric virus 
 











Figure Legends 1 
 2 
Figure 1. San José Province depicting the location of the five wastewater treatment plants 3 
included in the study. The San José Province is located at an altitude of 760 – 1,230 m 4 
above sea level and has an average temperature of 22°C year-round. Annual average 5 
precipitation ranges from 2,000–3,000 mm.  6 
 7 
Figure 2. Global somatic coliphage and fecal coliform concentrations at influent and 8 
effluent of WWTP by sampling period. 9 
 10 
Figure 3. Area under Receiver Operating Characteristic (ROC) curve for the multiple 11 
logistic regression model of somatic coliphage concentrations as a function of human 12 
enteric virus detection in conventional activated sludge WWTP effluent. 13 
 14 
Figure 4. The estimated annual disease burden for an adult farmer indirectly irrigating with 15 
wastewater treatment plant effluent below the somatic coliphage threshold, which was 16 
estimated for norovirus genotype I (NoV), enterovirus (EV), hepatitis A (HAV, as well as 17 
cumulatively considering the three aforementioned viruses. The dashed red line identifies 18 
the World Health Organization’s annual recommended limit for the additional disease 19 
burden caused by wastewater reuse (10
-4
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